IRVINE, Calif., June 25, 2013 /PRNewswire/ High Performance Nutrition (HPN) today announced the launch of
N(R)
TM, an innovative daily nutritional supplement designed to protect against axon degeneration damage or
trauma sustained in the course of playing contact sports. N(R) is one of the first commercially available products
to feature the ingredient NIAGEN
TM from ChromaDex Corporation® (OTCBB: CDXC), an innovative natural
products company that provides proprietary, sciencebased solutions and ingredients to the dietary
supplement, food and beverage, animal health, cosmetic and pharmaceutical industries.
ChromaDex Inc. developed its breakthrough ingredient NIAGEN as the patentprotected and first and only
commercially available brand of nicotinamide riboside, which is known to boost levels of NAD+ in the cells.
Studies have demonstrated that increasing the production of NAD+ can protect against axon degeneration
caused by mechanical or neurological injury
Recent studies have demonstrated that the head trauma that occurs in contact sports can lead to brain
damage. The prevalence of repeated blows to the head in contact sports such as football, soccer and hockey
has raised the concern of scientists, public officials, athletes and parents. Sean Torbati, CEO and president of
HPN, believes in the importance and responsibility of protecting the health of athletes, especially that of
America's youth, from debilitating brain injuries. His company has tapped into NIAGEN as a protective measure
with the introduction of N(R)
TM
"N(R) addresses the recent discovery that protection from brain injury should start off the field before it continues
on the field with barriers such as helmets," said Torbati. "About three million children younger than 14 play
organized tackle football in the United States, not to mention the millions playing competitively in high school,
college and beyond, as well as the millions more engaging in other sports in which helmets are worn such as
baseball, lacrosse, hockey or even horseback riding. Recent findings that athletes playing soccer are also at risk
for brain injury further demonstrates the potential for N(R) to be used by athletes worldwide."
Frank Jaksch, founder and CEO of ChromaDex, states "HPN is forging into a new and innovative market with N(R)
by aiming to prevent or delay axonal degeneration before trauma even occurs. Backed by scientific evidence
and patented nutrition technology [US7776326], N(R) is poised to revolutionize how players of contact sports
think about potentially protecting themselves in the long run."
Sean Torbati further comments, "An asset as important as the human brain deserves the most protection
possible, not just when you step onto the field and put on that helmet. It's a nobrainer."
For more information, please visit
www.HPNUltra.com
About Nicotinamide Riboside (NR):
Sometimes referred to as the "Miracle Molecule" or the "Hidden Vitamin," NR is found naturally in trace amounts
in milk and other foods and is a more potent, noflush version of Niacin (vitamin B3). The beneficial effects of NR
in humans include increased fatty acid oxidation, mitochondrial activity, resistance to the negative
consequences of highfat diets, protection against oxidative stress, prevention of peripheral neuropathy and the
blocking muscle degeneration.
Published research has shown that NR is perhaps the most potent precursor to NAD+ in the mitochondria of
animals. NAD+ is arguably the most important cellular cofactor for improvement of mitochondrial performance
and energy metabolism. Mitochondria also play an important part in the aging process. It is hoped that by
stimulating mitochondrial function with the NR molecule, scientists may see increased longevity as well as other
health improvements. Researchers worldwide continue their seminal discoveries in providing evidence for
unique properties of NR in neuroprotection, sirtuin activation, protection against weight gain on high fat diets
and improvement of blood glucose and insulin sensitivity.
About HPN
HPN LLC was founded in 2010 with its mission being to set a new standard for quality, safety, innovation and
effectiveness in the natural sports nutrition industry. The "no compromises" approach to every aspect of HPN's
product development, manufacturing and testing sets the company apart from the rest of the sports nutrition
category.
About ChromaDexr®
ChromaDex® is an innovative natural products company that discovers, acquires, develops and commercializes
proprietarybased ingredient technologies through its unique business model which utilizes its wholly owned
synergistic business units, including ingredient technologies, natural product fine chemicals (known as
"phytochemicals"), chemistry and analytical testing services and product regulatory and safety consulting (as
Spherix Consulting). The company provides seamless sciencebased solutions to the dietary supplement, food
and beverage, animal health, cosmetic and pharmaceutical industries. Our ingredient technologies unit
includes products backed with extensive scientific research and intellectual property. The
ingredient portfolio
includes pTeroPure®; pterostilbene; ProC3G™, a natural black rice containing cyanidine3glucoside;
PURENERGY™, a caffeinepTeroPure cocrystal; nutraGac™, a gac fruit powder; curcumin; and NIAGEN™, its
recently launched branded
nicotinamide riboside, a novel nextgeneration Bvitamin. To learn more about
ChromaDex please visit www.chromadex.com.
ForwardLooking Statements:
Any statements that are not historical facts contained in this release are forwardlooking statements. Actual
results may differ materially from those projected or implied in any forwardlooking statements. Such statements
involve risks and uncertainties, including but not limited to those relating to product and customer demand,
market acceptance of our products, the effect of economic conditions both nationally and internationally,
ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against
us, competition from other providers and products, risks in product development, our ability to raise capital to
fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in
the company's Securities and Exchange Commission filings. The company undertakes no obligation to update or
revise any forwardlooking statement for events or circumstances after the date on which such statement is
made except as required by law.
